Development of “chemical-antibody”, the novel aptamer probes, to target tumor cells and disease-related proteins for the molecular elucidation of cancer; Development of aptamer-based nanobiosensors and fullerene based nanoprobes for diagnostic and therapeutic applications, including ultrasensitive protein/glucose sensors, multifunctional imaging probes and efficient capture and release of circulating tumor cells.